ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GPCB Gpc Biotech AG ADS (MM)

0.94
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Gpc Biotech AG ADS (MM) NASDAQ:GPCB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.94 0 01:00:00

Gpc Biotech Ag - Report of Foreign Issuer (6-K)

06/11/2007 1:01pm

Edgar (US Regulatory)



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

November 06, 2007

Commission File Number: 000-50825


GPC BIOTECH AG

(Translation of registrant's name into English)


Fraunhoferstrasse 20
D-82152 Martinsried/Munich, Germany

(Address of principal executive offices)


Indicate by check mark whether the registrant files or will

file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   X            Form 40-F      

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):      

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):      

 

Indicate by check mark whether the registrant by furnishing the

information contained in this form is also thereby furnishing the

information to the Commission pursuant to Rule 12g3-2(b) under the

Securities Exchange Act of 1934.

Yes            No   X  

 

If “Yes” is marked, indicate below the file number assigned to the

registrant in connection with Rule 12g3-2(b): 82- .



Index: Exhibit 99.1   Announcement acc. to Sec. 15 WpHG.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

GPC BIOTECH AG
Date : November 06, 2007 By: /s/ Bernd Seizinger      
Name: Bernd Seizinger, M.D., Ph.D.
                                                                                                                          Title: CEO
 

GPC BIOTECH AG
Date : November 06, 2007 By: /s/ Mirko Scherer     
Name: Mirko Scherer, Ph.D.
                                                                                                                          Title: Senior Vice President and CFO
 


Exhibit Index
 
Exhibit No.

  
Description

EX-99.1
  
Announcement acc. to Sec. 15 WpHG.
 



1 Year Gpc Biotech AG ADS (MM) Chart

1 Year Gpc Biotech AG ADS (MM) Chart

1 Month Gpc Biotech AG ADS (MM) Chart

1 Month Gpc Biotech AG ADS (MM) Chart